159 related articles for article (PubMed ID: 29767995)
1. Structure-Activity Relationships and Therapeutic Potentials of 5-HT
Modica MN; Lacivita E; Intagliata S; Salerno L; Romeo G; Pittalà V; Leopoldo M
J Med Chem; 2018 Oct; 61(19):8475-8503. PubMed ID: 29767995
[TBL] [Abstract][Full Text] [Related]
2. Targeting the Serotonin 5-HT7 Receptor in the Search for Treatments for CNS Disorders: Rationale and Progress to Date.
Nikiforuk A
CNS Drugs; 2015 Apr; 29(4):265-75. PubMed ID: 25721336
[TBL] [Abstract][Full Text] [Related]
3. Modulation of Serotonin Receptors in Neurodevelopmental Disorders: Focus on 5-HT7 Receptor.
Lee J; Avramets D; Jeon B; Choo H
Molecules; 2021 Jun; 26(11):. PubMed ID: 34199418
[TBL] [Abstract][Full Text] [Related]
4. In Vitro and In Silico Analysis of the Residence Time of Serotonin 5-HT
Penna E; Niso M; Podlewska S; Volpicelli F; Crispino M; Perrone-Capano C; Bojarski AJ; Lacivita E; Leopoldo M
ACS Chem Neurosci; 2022 Feb; 13(4):497-509. PubMed ID: 35099177
[TBL] [Abstract][Full Text] [Related]
5. Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders.
Leopoldo M; Lacivita E; Berardi F; Perrone R; Hedlund PB
Pharmacol Ther; 2011 Feb; 129(2):120-48. PubMed ID: 20923682
[TBL] [Abstract][Full Text] [Related]
6. Discovery of Nonracemic Amisulpride to Maximize Benefit/Risk of 5-HT7 and D2 Receptor Antagonism for the Treatment of Mood Disorders.
Hopkins SC; Wilkinson S; Corriveau TJ; Nishikawa H; Nakamichi K; Loebel A; Koblan KS
Clin Pharmacol Ther; 2021 Sep; 110(3):808-815. PubMed ID: 33961287
[TBL] [Abstract][Full Text] [Related]
7. Radiosynthesis and in vivo evaluation of novel radioligands for PET imaging of cerebral 5-HT7 receptors.
Hansen HD; Herth MM; Ettrup A; Andersen VL; Lehel S; Dyssegaard A; Kristensen JL; Knudsen GM
J Nucl Med; 2014 Apr; 55(4):640-6. PubMed ID: 24566002
[TBL] [Abstract][Full Text] [Related]
8. The microRNA-29a Modulates Serotonin 5-HT7 Receptor Expression and Its Effects on Hippocampal Neuronal Morphology.
Volpicelli F; Speranza L; Pulcrano S; De Gregorio R; Crispino M; De Sanctis C; Leopoldo M; Lacivita E; di Porzio U; Bellenchi GC; Perrone-Capano C
Mol Neurobiol; 2019 Dec; 56(12):8617-8627. PubMed ID: 31292861
[TBL] [Abstract][Full Text] [Related]
9. The serotonin receptor 7 and the structural plasticity of brain circuits.
Volpicelli F; Speranza L; di Porzio U; Crispino M; Perrone-Capano C
Front Behav Neurosci; 2014; 8():318. PubMed ID: 25309369
[TBL] [Abstract][Full Text] [Related]
10. Dual effect of serotonin on the dendritic growth of cultured hippocampal neurons: Involvement of 5-HT
Rojas PS; Aguayo F; Neira D; Tejos M; Aliaga E; Muñoz JP; Parra CS; Fiedler JL
Mol Cell Neurosci; 2017 Dec; 85():148-161. PubMed ID: 28974382
[TBL] [Abstract][Full Text] [Related]
11. Serotonin 5-HT7 receptor increases the density of dendritic spines and facilitates synaptogenesis in forebrain neurons.
Speranza L; Labus J; Volpicelli F; Guseva D; Lacivita E; Leopoldo M; Bellenchi GC; di Porzio U; Bijata M; Perrone-Capano C; Ponimaskin E
J Neurochem; 2017 Jun; 141(5):647-661. PubMed ID: 28122114
[TBL] [Abstract][Full Text] [Related]
12. Pharmacophore Comparison and Development of Recently Discovered Long Chain Arylpiperazine and Sulfonamide Based 5-HT7 Ligands.
Rague A; Tidgewell K
Mini Rev Med Chem; 2018; 18(7):552-560. PubMed ID: 28901854
[TBL] [Abstract][Full Text] [Related]
13. Current Limitations and Candidate Potential of 5-HT7 Receptor Antagonism in Psychiatric Pharmacotherapy.
Okubo R; Hasegawa T; Fukuyama K; Shiroyama T; Okada M
Front Psychiatry; 2021; 12():623684. PubMed ID: 33679481
[TBL] [Abstract][Full Text] [Related]
14. Discovery of G Protein-Biased Ligands against 5-HT
Lee J; Kwag R; Lee S; Kim D; Woo J; Cho Y; Kim HJ; Kim J; Jeon B; Choo H
J Med Chem; 2021 Jun; 64(11):7453-7467. PubMed ID: 34032427
[TBL] [Abstract][Full Text] [Related]
15. Novel N-biphenyl-2-ylmethyl 2-methoxyphenylpiperazinylalkanamides as 5-HT7R antagonists for the treatment of depression.
Kim Y; Tae J; Lee K; Rhim H; Choo IH; Cho H; Park WK; Keum G; Choo H
Bioorg Med Chem; 2014 Sep; 22(17):4587-96. PubMed ID: 25127461
[TBL] [Abstract][Full Text] [Related]
16. Computer-aided insights into receptor-ligand interaction for novel 5-arylhydantoin derivatives as serotonin 5-HT
Kucwaj-Brysz K; Kurczab R; Jastrzębska-Więsek M; Żesławska E; Satała G; Nitek W; Partyka A; Siwek A; Jankowska A; Wesołowska A; Kieć-Kononowicz K; Handzlik J
Eur J Med Chem; 2018 Mar; 147():102-114. PubMed ID: 29425815
[TBL] [Abstract][Full Text] [Related]
17. The 5-HT7 receptor triggers cerebellar long-term synaptic depression via PKC-MAPK.
Lippiello P; Hoxha E; Speranza L; Volpicelli F; Ferraro A; Leopoldo M; Lacivita E; Perrone-Capano C; Tempia F; Miniaci MC
Neuropharmacology; 2016 Feb; 101():426-38. PubMed ID: 26482421
[TBL] [Abstract][Full Text] [Related]
18. Serotonin 5-HT
Petelák A; Lambert NA; Bondar A
Mol Biol Cell; 2023 Aug; 34(9):br14. PubMed ID: 37342875
[TBL] [Abstract][Full Text] [Related]
19. [Possible involvement of 5-HT₇ receptor in pathophysiology of affective disorders and action of antidepressant drugs].
Tokarski K; Kusek M; Sowa J; Bobula B
Postepy Hig Med Dosw (Online); 2014 Sep; 68():1104-13. PubMed ID: 25228519
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of new homo and hetero bis-piperazinyl-1-propanone derivatives as 5-HT7R selective ligands over 5-HT1AR.
Intagliata S; Modica MN; Pittalà V; Salerno L; Siracusa MA; Cagnotto A; Salmona M; Romeo G
Bioorg Med Chem Lett; 2016 Aug; 26(16):4052-6. PubMed ID: 27396505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
